#monoclonal antibodies

1 story

#africa #bharat biotech #covaxin #ebola vaccine #gene therapy #india #ipo #krishna ella #nipah vaccine #tb vaccine

Bharat Biotech Returns to Innovation After Pandemic
Bharat Biotech founder Krishna Ella reveals post-Covid reset, TB vaccine progress, and future focus on Africa.
The Economic Times · 1m